Below are some of the latest senior practitioner moves and firm news across the world. Readers should note that firm and practitioner news can also be found on a firm's review page. EUROPE
Continue reading
• Royalty Pharma to acquire an interest in SPINRAZA® and pelacarsen royalties – Ionis retains majority of royalties and all milestones from Novartis for pelacarsen • Royalty Pharma to pay Io...
Continue reading
Olpasiran is an siRNA therapeutic being developed by Amgen to reduce risk of cardiovascular disease Arrowhead retains rights to $400 million in development, regulatory and sales milestone payments
Continue reading
All press coverage
Maiwald GmbH in Munich has achieved an important victory for its client Acetate International LLC at the European Patent Office. Acetate International LLC is part of the Celanese group which has a long history of producing cellulose acetate products for commercial applicatio...
Continue reading
Munich, 11 October 2022 - Maiwald, one of Germany's largest and most renowned law firms in the field of intellectual property, will in future operate under a new name: Effective October 11, 2022, Maiwald Patentanwaltsgesellschaft und Rechtsanwaltsgesellschaft mbH changed its...
Continue reading
The patent attorneys’ firm of Maiwald has put part of its Munich office space at the disposal of the organisation “Münchner Freiwillige – Wir helfen e.V.” to use as a contact point for refugees fleeing Ukraine. From rooms in Elisenhof, located very close to...
Continue reading
All press releases